Report Company Directory

Optimax Technology

• Ford Equity International Rating and Forecast Report by Ford Equity Research

Optimi Health

• Optimi Health Secures Import Permit from Mind Medicine Australia for MDMA and Psilocybin Capsules by GlobeNewsWire
• Optimi Health, ATMA Sign Letter of Intent To Advance Phase II Clinical Trial Group and Individual Administration Protocol For Major Depressive Disorder by GlobeNewsWire
• Optimi Health Receives Certificate of Analysis For MDMA 40mg and 60mg GMP Capsules by GlobeNewsWire
• Optimi Health Provides Corporate Update by GlobeNewsWire
• Optimi Health Receives Export Permit from Health Canada to Ship MDMA To Tel Aviv University's Institute for Psychedelic Research by GlobeNewsWire
• Optimi Health and Kwantlen Polytechnic University Applied Genomics Centre Partner to Advance Mushroom Science and Research by GlobeNewsWire
• Optimi Health Achieves Milestone: Completes In-House Production of MDMA Active Pharmaceutical Ingredient (API) by GlobeNewsWire
• Optimi Health Signs Psilocybin Supply Agreement With New Zealand-Based Mātai Medical Research Institute by GlobeNewsWire
• Optimi Health Receives Finished Product Test Results and Certificate Of Analysis for GMP Natural Psilocybin Extract by GlobeNewsWire
• Optimi Health Confirms Presenting Sponsorship at the 4th Annual Psychedelic Therapeutics and Drug Development Conference by GlobeNewsWire

OPTIMIX INCOME FUND

OptimizeRx Corp

• OptimizeRx Continues Expansion of the Company’s Point-Of-Care Network by GlobeNewsWire
• Final Reminder, Tomorrow: Fireside Chat With Chris Schremser, Chief Technology Officer and Head of Engineering for Waystar (WAY) by William Blair
• William Blair Thinking Podcast: The Growing Importance of AI in the Revenue Cycle Management Marketplace by William Blair
• William Blair’s 2026 Top Picks Discussions: December 8–12, 2025 by William Blair
• Final Reminder for EVH Client Conversation Spotlight; Wednesday, December 3 at 11:00 a.m. CT: CMO of a Large Medicaid Health Plan by William Blair
• William Blair’s 2026 Top Picks Discussions: December 8–12, 2025 by William Blair
• Healthcare Checkup: Top 5 Macro Focal Points, Top 5 Highest Interest Stocks Post Earnings; Updated Stock Sentiment Tracker by William Blair
• William Blair’s 2026 Top Picks Discussions: December 8–12, 2025 by William Blair
• OptimizeRx Reports Third Quarter 2025 Financial Results and Increases Fiscal Year 2025 Guidance by GlobeNewsWire
• OptimizeRx Sets Third Quarter 2025 Conference Call for November 6, 2025, at 4:30 p.m. ET by GlobeNewsWire

OptimizeRx Corp

• Reminder: Fireside Chat With Chris Schremser, Chief Technology Officer and Head of Engineering for Waystar (WAY) by William Blair
• Reminder: EVH Client Conversation Spotlight – December 3 at 11:00 a.m. CT: CMO of a Large Medicaid Health Plan by William Blair
• William Blair’s 2026 Top Picks Discussions: December 8–12, 2025 by William Blair
• Save the Date: Fireside Chat With Chris Schremser, Chief Technology Officer and Head of Engineering for Waystar (WAY) by William Blair
• The Growing Importance of AI in the Revenue Cycle Management Marketplace by William Blair
• EVH Client Conversation Spotlight – December 3 at 11:00 a.m. CT: CMO of a Large Medicaid Health Plan by William Blair
• Positive Third-Quarter Print as Growth Story Shows No Sign of Slowing, Guidance Increased Again by William Blair
• Third-Quarter Earnings Preview: Key Themes to Monitor, Top Stock Ideas, and Our Bull/Bear Thesis and Stock Catalyst Tracker by William Blair
• Third-Quarter Earnings Preview Call With Ryan Daniels by William Blair
• Save the Date for Our Annual “Client Convo” Week: Talking to Key Customers and Partners of Our Covered Companies by William Blair